These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37572122)

  • 41. Pelvic Organ Prolapse Severity and Genital Hiatus Size With Long-Term Pessary Use.
    Boyd SS; Subramanian D; Propst K; O'Sullivan D; Tulikangas P
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e360-e362. PubMed ID: 32910077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case series: Vaginal pessary for pelvic organ prolapse and its association with vaginal cancer.
    Tan ACC; Faiz MJ
    Med J Malaysia; 2021 Nov; 76(6):910-913. PubMed ID: 34806683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Complications related to pessary use in the treatment of female pelvic organ prolapse].
    Mooij R; Potijk TM; Schrickx JA
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaginal pessaries for pelvic organ prolapse and urinary incontinence: a multiprofessional survey of practice.
    Bugge C; Hagen S; Thakar R
    Int Urogynecol J; 2013 Jun; 24(6):1017-24. PubMed ID: 23179500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Pessary vs Surgery on Patient-Reported Improvement in Patients With Symptomatic Pelvic Organ Prolapse: A Randomized Clinical Trial.
    van der Vaart LR; Vollebregt A; Milani AL; Lagro-Janssen AL; Duijnhoven RG; Roovers JWR; van der Vaart CH
    JAMA; 2022 Dec; 328(23):2312-2323. PubMed ID: 36538310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
    Sung VW; Wohlrab KJ; Madsen A; Raker C
    Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pessaries for pelvic organ prolapse: evaluation of vaginal discharge and pain during pessary cleaning in an outpatient setting.
    Kruyt LM; van der Ploeg JM; Lammers K; van Etten-Debruijn BA; Niemeijer AS; Hakvoort RA
    Int Urogynecol J; 2024 Feb; 35(2):333-339. PubMed ID: 37796331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors for unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: a prospective study.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    BJOG; 2018 Oct; 125(11):1434-1440. PubMed ID: 29700950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of vaginal estrogen on pessary use.
    Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
    Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parameters associated with unsuccessful pessary fitting for pelvic organ prolapse up to three months follow-up: a systematic review and meta-analysis.
    Manzini C; Morsinkhof LM; van der Vaart CH; Withagen MIJ; Grob ATM
    Int Urogynecol J; 2022 Jul; 33(7):1719-1763. PubMed ID: 35037973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse.
    Dwyer L; Bugge C; Hagen S; Goodman K; Agur W; Dembinsky M; Graham M; Guerrero K; Hemming C; Khunda A; McClurg D; Melone L; Thakar R; Kearney R;
    Trials; 2022 Sep; 23(1):742. PubMed ID: 36064727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful use of ring pessary with support for advanced pelvic organ prolapse.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Int Urogynecol J; 2015 Oct; 26(10):1517-23. PubMed ID: 25982787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Location and motion of vaginal pessaries in situ in women with successful and unsuccessful pessary treatment for pelvic organ prolapse.
    Boogaard LL; Triepels CPR; Verhamme LM; van Kuijk SMJ; Donners JJAE; Kluivers KB; Maal TJJ; Weemhoff M; Notten KJB
    Int Urogynecol J; 2023 Sep; 34(9):2293-2300. PubMed ID: 37119269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse.
    Alperin M; Khan A; Dubina E; Tarnay C; Wu N; Pashos CL; Anger JT
    Female Pelvic Med Reconstr Surg; 2013; 19(3):142-7. PubMed ID: 23611931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Compliance of Self-Care Pessary in Symptomatic Pelvic Organ Prolapse.
    Charoenloet N; Srisukho S; Phongnarisorn C; Tongsong T; Rujijanakul Y
    Int Urogynecol J; 2024 Jun; 35(6):1263-1269. PubMed ID: 38748222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adherence to support pessary in the treatment of pelvic organ prolapse: a retrospective study conducted among 1,371 women.
    Brandt CH; Yamolaei M; Wu C; Hansen UD; Rasch V
    Int Urogynecol J; 2024 Jan; 35(1):69-75. PubMed ID: 37548745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery.
    Coolen AWM; Troost S; Mol BWJ; Roovers JPWR; Bongers MY
    Int Urogynecol J; 2018 Jan; 29(1):99-107. PubMed ID: 28600758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.